NCT07141706 2026-04-09A Study of DB-1317 in Selected Advanced/Metastatic Solid TumorsDualityBio Inc.Phase 1 Recruiting233 enrolled
NCT07480681 2026-03-18Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HLX97 (a KAT6A/B Inhibitor) in Patients With Advanced/Metastatic Solid TumorShanghai Henlius BiotechPhase 1 Not yet recruiting138 enrolled
NCT07473726 2026-03-16A Phase I Clinical Study to Evaluate the Safety, Tolerability, and PK of HLX48 in Advanced/Metastatic Solid TumorsShanghai Henlius BiotechPhase 1 Not yet recruiting72 enrolled
NCT07274813 2026-03-03A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid TumorsShanghai Henlius BiotechPhase EARLY_PHASE1 Recruiting254 enrolled
NCT07415863 2026-02-17Phase 1/II Clinical Study of SYS6043 in the Treatment of Advanced/Metastatic Solid TumorsCSPC Megalith Biopharmaceutical Co.,Ltd.Phase 1/2 Recruiting820 enrolled